Given its involvement in cancer, high levels of AURKA have been linked to clinical aggressiveness, poor outcomes, unfavourable prognoses, therapeutic resistance, and increased early recurrence in HCC patients.80, 84. This evidence concerns the gene AURKA and hepatocellular carcinoma.